The Incidence of Inborn errors of metabolism (IEMs) 

The Incidence of Inborn errors of metabolism (IEMs) 
Inborn errors of metabolism (IEMs) individually are rare but collectively are common. Presentation is usually in the neonatal period or infancy but can occur at any time, even in adulthood. Diagnosis does not require extensive knowledge of biochemical pathways or individual metabolic diseases. An understanding of the major clinical manifestations of inborn errors of metabolism provides the basis for knowing when to consider the diagnosis. A high index of suspicion is most important in making the diagnosis.

For patients with suspected or known inborn errors of metabolism, successful emergency treatment depends on prompt institution of therapy aimed at metabolic stabilization. Asymptomatic neonates with newborn screening results positive for an inborn error of metabolism may require emergent evaluation including confirmatory testing, and as appropriate, initiation of disease-specific management.

The Incidence of Inborn errors of metabolism (IEMs) 

  • The incidence, collectively, is estimated to be as high as 1 in 800 live births. The frequencies for each individual inborn error of metabolism vary, but most are very rare. Of term infants who develop symptoms of sepsis without known risk factors, as many as 20% may have an inborn error of metabolism.
  • The overall incidence and the frequency for individual diseases varies based on racial and ethnic composition of the population and on extent of screening programs.  Overall rates are in a range similar to that of the United States.
  • Mortality can be very high for certain inborn errors of metabolism (IEMs), particularly those that present in neonates, but initial presentation of IEM even in adults may result in death. Prompt treatment of acute decompensation can be life-saving and is critical to optimizing outcome.
  • Inborn errors of metabolism (IEMs) can affect any organ system and usually affect multiple organ systems resulting in morbidity due to acute and/or chronic organ dysfunction.
  • Progression may be unrelenting with rapid life-threatening deterioration over hours, episodic with intermittent decompensations and asymptomatic intervals, or insidious with slow degeneration over decades.
  • Consider IEMs in all neonates and young infants with unexplained death. Obtain specimens immediately postmortem in children with unexplained death.
  • The incidence within different racial and ethnic groups varies with predominance of certain inborn errors of metabolism (IEMs) within particular groups (eg, cystic fibrosis, 1 per 1600 people of European descent; sickle cell anemia, 1 per 600 people of African descent; Tay-Sachs, 1 per 3500 Ashkenazi Jews).
  • The mode of inheritance determines the male-to-female ratio of affected individuals.
  • Many inborn errors of metabolism (IEMs) have multiple forms that differ in their mode of inheritance.
  • The male-to-female ratio is 1:1 for autosomal dominant and autosomal recessive transmission. It is also 1:1 for X-linked dominant if transmission is from mother to child.
  • Age for presentation of clinical symptoms varies for individual inborn errors of metabolism (IEM) and variant forms within the IEM with presentation from within hours of life to very late in adulthood. The timing of presentation depends on significant accumulation of toxic metabolites or on the deficiency of substrate.
  • The onset and severity may be exacerbated by environmental factors such as diet and intercurrent illness.
  • Disorders of protein or carbohydrate intolerance and disorders of energy production tend to present in the neonatal period or early infancy and tend to be unrelenting and rapidly progressive. Less severe variants of these diseases usually present later in infancy or childhood and tend to be episodic.
  • Fatty acid oxidation defects, glycogen storage, and lysosomal storage disorders tend to present in infancy or childhood. Disorders manifested by subtle neurologic or psychiatric features often go undiagnosed until adulthood

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s